The news: Wuhan and its surrounding province, Hubei, had no new cases of coronavirus to report today, according to the Chinese state media. It’s a remarkable turnaround for the city where coronavirus originated, which was only very recently struggling to cope with thousands of sick people requiring hospitalization. All of the 34 new cases recorded the day before were people from abroad, Chinese officials said.
This story is part of our ongoing coverage of the coronavirus/Covid-19 outbreak, which is available free of charge. You can also sign up to our dedicated newsletter.
Cause for optimism? The news from Hubei offers a glimmer of hope, and perhaps some lessons to governments on what works. The main one seems to be the need to put affected populations on strict lockdown at an early stage. This happened in Wuhan: it's still the case that only those with special permission can travel in and out, and people are instructed to stay inside their homes. This order will be lifted only if no additional cases are reported for two consecutive weeks, according to Li Lanjuan, a member of the Chinese Academy of Engineering. It is still possible that cases in Hubei will rebound when authorities eventually relax the lockdown.
A grim milestone: The virus’s epicenter is now arguably Italy, which is set to surpass China’s number of coronavirus-related deaths—3,250—this week. The region of Lombardy has been by far the worst-affected region, with hundreds of people dying every day.
Biotechnology and health
What to know about this autumn’s covid vaccines
New variants will pose a challenge, but early signs suggest the shots will still boost antibody responses.
A biotech company says it put dopamine-making cells into people’s brains
The experiment to treat Parkinson’s is a critical early test of stem cells’ potential to tackle serious disease.
Tiny faux organs could crack the mystery of menstruation
Researchers are using organoids to unlock one of the human body’s most mysterious—and miraculous—processes.
After 25 years of hype, embryonic stem cells are still waiting for their moment
Research roadblocks and political debates have delayed progress—but scientists are inching closer to delivering a cure.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.